Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-34c' Or cancer = '' Total: 32 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-34c mir-34 breast cancer down MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
hsa-mir-34c breast cancer down Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cells.
hsa-mir-34c breast cancer down The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer.
hsa-mir-34c breast cancer down MicroRNA-34c Suppresses Breast Cancer Migration and Invasion by Targeting GIT1.
hsa-mir-34c chronic lymphocytic leukemia down Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
hsa-mir-34c colon cancer down Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.
hsa-mir-34c colorectal cancer down Interrupted E2F1-miR-34c-SCF negative feedback loop by hyper-methylation promotes colorectal cancer cell proliferation.
hsa-mir-34c endometrial cancer down MiR-34c oligonucleotide enhances chemosensitivity of Ishikawa cell to cisplatin by inducing apoptosis.
hsa-mir-34c endometrial cancer down miR-34c plays a role of tumor suppressor in HEC?1-B cells by targeting E2F3 protein.
hsa-mir-34c gastric cancer down Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
hsa-mir-34c hepatoblastoma down Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.
hsa-mir-34c lung cancer down Uncovering growth-suppressive MicroRNAs in lung cancer.
hsa-mir-34c mir-34 lung cancer down Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.
hsa-mir-34c malignant melanoma down Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene.
hsa-mir-34c medulloblastoma up Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-34c nasopharyngeal carcinoma down MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
hsa-mir-34c nasopharyngeal carcinoma down MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.
hsa-mir-34c osteosarcoma down MiR-34c inhibits osteosarcoma metastasis and chemoresistance.
hsa-mir-34c mir-34 osteosarcoma down Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
hsa-mir-34c mir-34 ovarian cancer down Frequent downregulation of miR-34 family in human ovarian cancers.
hsa-mir-34c ovarian carcinoma down MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
hsa-mir-34c mir-34 pancreatic cancer down MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
hsa-mir-34c mir-34 pancreatic cancer down miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA.
hsa-mir-34c prostate cancer down miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
hsa-mir-34c uveal melanoma down MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
hsa-mir-34c-3p glioma down Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells.
hsa-mir-34c-3p hepatocellular carcinoma down miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.
hsa-mir-34c-3p hepatocellular carcinoma up MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
hsa-mir-34c-3p non-small cell lung cancer down MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
hsa-mir-34c-3p non-small cell lung cancer down Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells.
hsa-mir-34c-5p colorectal cancer down SATB2 targeted by methylated miR-34c-5p suppresses proliferation and metastasis attenuating the epithelial-mesenchymal transition in colorectal cancer.
hsa-mir-34c-5p glioma down Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells.